Научная литература
booksshare.net -> Добавить материал -> Медицина -> Джордж А.Г. -> "Анестезия и педиатрия" -> 584

Анестезия и педиатрия - Джордж А.Г.

Джордж А.Г. Анестезия и педиатрия — М.: Медицина, 2003. — 1192 c.
ISBN 5-225-03821-2
Скачать (прямая ссылка): anesteziyavpedeatrii2003.djvu
Предыдущая << 1 .. 578 579 580 581 582 583 < 584 > 585 586 587 588 589 590 .. 1012 >> Следующая

48. Beghetti M, SilhoffPE, Caramori M, et al: Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury. Ann Thorac Suig 66:532, 1998
49. Haworth SG: Total anomalous pulmonary venous return. Prenatal damage to pulmonary vascular bed and extrapul-monaiy veins. Br Heart J 48:513, 1982
50. Atz AM, Adatia I, Wessel DL: Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Suig 62:1759, 1996
51. Adetia I, Atz AM, Jonas RA, Wessel DL: Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. J Thorac Cardiovasc Suig 112:1403, 1996
52. Joumois D, Pouard P, Mauriat P, et al: Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Suig 107:1129, 1994
53. Lucieni GB, Chang AC, Starnes VA: Surgical repair of transposition of the great arteries in neonates with persistent pulmonary hypertension. Ann Thorac Suig 61:800, 1996
54. Rusell ІА, Zwass MS, Fineman JR, et al: The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undeigoing surgical repair of congenital heart disease. Anesth Analg 87:46, 1990
55. Roberts JD, Lang P, Bigatello LM, el al: Inhaled nitric oxide in congenital heart disease. Circulation 87:447, 1993
56. Dukarm RC, Morin FC, Russell JA, Steinhom RH: Pul-
6М Анестезия в педиатрии
monary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with peisistent pul* monaiy hypertension. Pediatr Res 44:831, 1998
57. Yahagi N, Kumon K, Tanigami H: Inhaled nitric oxide for the postoperative management of Fontan-type operations. Ann Thorac Suig 57:1371, 1994
58. Miller Ol, Cetermajer DS, Deanfietd JE, Macrae DJ: Very low dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Suig 108:487, 1994
59. Beghetti M, Habrc W, Friedli B, Berner M: Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in peediatric patients. Br Heart J 73:65, 1995
60. Leclerc F, Riou У, Martino* A, et al: Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia. Intensive Care Med 20:511, 1994
61. Thompson MW, Bates JN, Klein JM: Treatment of respiratory failure in an infaut with bronchopulmonary dysplasia infected with respiratory syncytial virus nsing inhaled nitric oxide and high frequency ventilation. Acta Paediatr 84:100, 1995
62. Ogura H, Cioffi WO, Oflfner PJ, et al: Effect of inhaled nitric oxide on pulmonary function after sepsis in a swine model. Suigery Il6:313, 1994
63. Channick RN, Newhart JW, Johnson FW, et al: Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension. Chest 109:1545, 1996
64. Ivy DD, Griebel JL, Kinsella JP, Abman SH: Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension. J Pediatr 133:453, 1998
65. Roberts JD, Roberts CT, Jones RC, et al: Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res 76:215,1995
66. Atz AM, Wessel DL* Inhaled nitric oxide and heparin for infantile primary pulmonary hypertension. Lancet 351:1701, 1998
67. Young JD, Sear JW, Valvini EM: Kinetics of methaemo-globin and serum nitrogen oxide production during inhe-lation of nitric oxide in volunteers. Br J Anaesth 76:652, 1996
68. Rimar S, Gillis CN: Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88:2884, 1993
69. Hallman M, Bry K, Lappalainen U: A mechanism of nitric oxide-induced surfactant dysfunction. J Appl Physiol 00:2035, 1996
70. Semigran MJ, Cockrill BA, Kacmarek R, et al: Hemodynamic effects of inheled nitric oxide in heart failure. J Am Coll Cardiol 24:982, 1994
71. Loh E, Stamler JS, Hare JM, etal: Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 98:2700, 1994
72. Bocchi EA, Bacal F, Auter JOC, et al: Inhaled nitric oxide leading to pulmonary ndema in stable severe heart failure. Am J Ceidiol 74:70, 1994
73. Hare JM, Sheman SK, Body SC, et a|: Influence of in-halnd nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance. Circulation 95:2250, 1997
74. Francoise M, Gouyon JB, Mercier JC: Hemodynamic and oxygenation changes induend by the discontinuation of low-dose inhalational nitric oxide in newborn infants. Intensive Care Med 22:477, 1996
75. Lavoie A, Hall JB, Olson DM, Wylam ME: Life-thrcat-ea і ng effects of discontinuing inhaled oltric oxide in severe respiratory failure. Am J Respir Crit Care Mnd 153:1985,
1996
76. Millar Ol, Tang SF, Keech A, Cetermajer DS: Rebound
pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 346:51, 1995
Предыдущая << 1 .. 578 579 580 581 582 583 < 584 > 585 586 587 588 589 590 .. 1012 >> Следующая

Реклама

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

Есть, чем поделиться? Отправьте
материал
нам
Авторские права © 2009 BooksShare.
Все права защищены.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed